focus -WSS

focus

author：focus 2025-08-26 07:45:14 - browse：51

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： CDC advisory panel says seniors 'may' get RSV vaccine

entertainment

WSS

Winners, losers from Medicare’s list of drugs subject to price talks

Teach medical students about patients with intellectual disabilities

Pfizer plans to depart BIO

AI models in health care face new federal disclosure requirements

How to make AI work for medicine

In science, is the line between industry and academia shifting?

entertainment

focus

entertainment

Guidelines to prevent youth baseball injuries need more muscle

STAT letters to the editor on burnt

Virginia high school admissions case could be legal follow

After sickle

At least 13 dead in Texas as scorching temps continue

Radiation, mainstay of cancer treatment, begins a fade

ChatGPT in medicine: STAT answers readers' burning questions

The woman behind the Dana Farber

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

hotspot

Pharma patents targeted by Biden in move to slash drug prices

How Long Island became the ‘eugenics capital of the world’

Medicare explains how it will choose drugs for negotiation

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Psilocybin's anti

Australia’s approach to dialysis celebrates life

Wikipedia

leisure time

focus

entertainment